2024 Q2 Form 10-Q Financial Statement

#000149315224019107 Filed on May 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q4
Revenue $9.060M $8.523M $8.077M
YoY Change 42.23% 110.97% 19.87%
Cost Of Revenue $6.179M $5.966M $5.441M
YoY Change 28.27% 79.54% 17.06%
Gross Profit $2.881M $2.557M $2.636M
YoY Change 85.51% 256.62% 26.12%
Gross Profit Margin 31.8% 30.0% 32.64%
Selling, General & Admin $1.266M $1.201M $935.0K
YoY Change 34.97% 20.22% 20.33%
% of Gross Profit 43.94% 46.97% 35.47%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $132.0K $117.0K $93.00K
YoY Change 55.29% 44.44% 8.14%
% of Gross Profit 4.58% 4.58% 3.53%
Operating Expenses $1.266M $1.201M $935.0K
YoY Change 34.97% 20.22% 20.33%
Operating Profit $1.615M $1.356M $1.701M
YoY Change 162.6% -580.85% 29.55%
Interest Expense $17.00K $9.000K -$24.00K
YoY Change 112.5%
% of Operating Profit 1.05% 0.66% -1.41%
Other Income/Expense, Net
YoY Change
Pretax Income $1.598M $1.347M $1.677M
YoY Change 163.26% -577.66% 27.72%
Income Tax $337.0K $285.0K $246.0K
% Of Pretax Income 21.09% 21.16% 14.67%
Net Earnings $1.261M $1.062M $1.431M
YoY Change 163.26% -576.23% 46.47%
Net Earnings / Revenue 13.92% 12.46% 17.72%
Basic Earnings Per Share $0.19 $0.16 $0.06
Diluted Earnings Per Share $0.18 $0.16 $0.21
COMMON SHARES
Basic Shares Outstanding 6.853M shares 6.824M shares 6.784M shares
Diluted Shares Outstanding 6.888M shares 6.823M shares 6.722M shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $486.0K $321.0K $1.204M
YoY Change -28.11% -74.92% 28.91%
Cash & Equivalents $486.0K $321.0K $1.200M
Short-Term Investments
Other Short-Term Assets $316.0K $404.0K $219.0K
YoY Change -28.51% 62.25% -33.23%
Inventory $15.12M $13.68M $12.15M
Prepaid Expenses $316.0K $404.0K $219.0K
Receivables $3.321M $3.680M $3.624M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $19.48M $18.34M $17.54M
YoY Change 29.66% 28.53% 31.04%
LONG-TERM ASSETS
Property, Plant & Equipment $1.192M $983.0K $998.0K
YoY Change 25.74% 0.61% 3.1%
Goodwill
YoY Change
Intangibles $969.0K $1.089M $0.00
YoY Change
Long-Term Investments
YoY Change
Other Assets $4.192M $4.477M $3.685M
YoY Change 8.04% 8.45% -11.99%
Total Long-Term Assets $5.384M $5.460M $4.683M
YoY Change 11.52% 6.95% -9.16%
TOTAL ASSETS
Total Short-Term Assets $19.48M $18.34M $17.54M
Total Long-Term Assets $5.384M $5.460M $4.683M
Total Assets $24.86M $23.80M $22.22M
YoY Change 25.25% 22.84% 19.86%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.709M $2.049M $810.0K
YoY Change 30.66% 42.99% 14.73%
Accrued Expenses $1.187M $1.089M $1.265M
YoY Change 33.37% 11.46% 32.05%
Deferred Revenue $320.0K $481.0K $481.0K
YoY Change 144.27% 47.55% 54.66%
Short-Term Debt $1.000M $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $5.237M $4.726M $4.077M
YoY Change 43.24% 4.51% 21.05%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $500.0K $1.000M
YoY Change -100.0%
Other Long-Term Liabilities $1.894M $2.113M $2.282M
YoY Change -25.08% -20.14% -17.35%
Total Long-Term Liabilities $1.894M $2.613M $3.282M
YoY Change -46.42% -1.25% 18.87%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.237M $4.726M $4.077M
Total Long-Term Liabilities $1.894M $2.613M $3.282M
Total Liabilities $7.131M $7.339M $7.359M
YoY Change -0.83% 2.39% 20.07%
SHAREHOLDERS EQUITY
Retained Earnings -$3.678M -$4.939M -$6.432M
YoY Change -56.42% -44.62% -26.03%
Common Stock $21.41M $21.40M $21.29M
YoY Change 1.47% 1.3% 0.9%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $17.73M $16.46M $14.86M
YoY Change
Total Liabilities & Shareholders Equity $24.86M $23.80M $22.22M
YoY Change 25.25% 22.84% 19.86%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q4
OPERATING ACTIVITIES
Net Income $1.261M $1.062M $1.431M
YoY Change 163.26% -576.23% 46.47%
Depreciation, Depletion And Amortization $132.0K $117.0K $93.00K
YoY Change 55.29% 44.44% 8.14%
Cash From Operating Activities $50.00K -$1.276M $1.105M
YoY Change -103.31% -382.93% 626.97%
INVESTING ACTIVITIES
Capital Expenditures $306.0K $1.139M $8.000K
YoY Change 446.43% 1165.56% -138.1%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$306.0K -$1.139M -$8.000K
YoY Change 446.43% 1165.56% -61.9%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 421.0K 363.0K -207.0K
YoY Change -56.33% -2520.0% -95.26%
NET CHANGE
Cash From Operating Activities 50.00K -1.276M 1.105M
Cash From Investing Activities -306.0K -1.139M -8.000K
Cash From Financing Activities 421.0K 363.0K -207.0K
Net Change In Cash 165.0K -2.052M 890.0K
YoY Change -127.32% -693.06% -121.02%
FREE CASH FLOW
Cash From Operating Activities $50.00K -$1.276M $1.105M
Capital Expenditures $306.0K $1.139M $8.000K
Free Cash Flow -$256.0K -$2.415M $1.097M
YoY Change -83.67% -768.98% 534.1%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
usd
CY2024Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
usd
CY2023Q4 OPXS Fair Value Of Contingent Liability
FairValueOfContingentLiability
usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
usd
us-gaap Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
usd
CY2024Q1 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
usd
CY2024Q1 OPXS Allocated Home Office Expense
AllocatedHomeOfficeExpense
usd
CY2023Q2 OPXS Allocated Home Office Expense
AllocatedHomeOfficeExpense
usd
OPXS Allocated Home Office Expense
AllocatedHomeOfficeExpense
usd
OPXS Allocated Home Office Expense
AllocatedHomeOfficeExpense
usd
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P5Y
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P5Y
CY2023Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
usd
CY2023Q2 OPXS Change In Fair Value Of Contingent Liability
ChangeInFairValueOfContingentLiability
usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments
usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments
usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
630000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
620000 usd
CY2023Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
247000 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1089000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1265000 usd
CY2024Q1 OPXS Accrued Selling Expense Current
AccruedSellingExpenseCurrent
258000 usd
CY2023Q4 OPXS Accrued Selling Expense Current
AccruedSellingExpenseCurrent
336000 usd
CY2024Q1 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
69000 usd
CY2023Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
75000 usd
CY2024Q1 OPXS Contract Loss Reserves Current
ContractLossReservesCurrent
150000 usd
CY2023Q4 OPXS Contract Loss Reserves Current
ContractLossReservesCurrent
243000 usd
CY2024Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
481000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
481000 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
4726000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4077000 usd
CY2024Q1 OPXS Credit Facility Noncurrent
CreditFacilityNoncurrent
500000 usd
CY2023Q4 OPXS Credit Facility Noncurrent
CreditFacilityNoncurrent
1000000 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2027000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2282000 usd
CY2024Q1 OPXS Fair Value Of Contingent Liability
FairValueOfContingentLiability
86000 usd
OPXS Increase Decrease In Accrued Estimated Loss On Contracts
IncreaseDecreaseInAccruedEstimatedLossOnContracts
-93000 usd
OPXS Increase Decrease In Accrued Estimated Loss On Contracts
IncreaseDecreaseInAccruedEstimatedLossOnContracts
-176000 usd
CY2023Q2 OPXS Stock Issued During Period Value Vested Restricted Stock Units Issued Net Of Tax Withholding
StockIssuedDuringPeriodValueVestedRestrictedStockUnitsIssuedNetOfTaxWithholding
-42000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
479000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
12659000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
14860000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
270000 usd
OPXS Stock Issued During Period Value Vested Performance Based Shares Net Of Withheld Taxes
StockIssuedDuringPeriodValueVestedPerformanceBasedSharesNetOfWithheldTaxes
-164000 usd
us-gaap Net Income Loss
NetIncomeLoss
1493000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
16459000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
12408000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
12408000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
53000 usd
OPXS Stock Issued During Period Value Vested Performance Based Shares Net Of Withheld Taxes
StockIssuedDuringPeriodValueVestedPerformanceBasedSharesNetOfWithheldTaxes
-58000 usd
us-gaap Net Income Loss
NetIncomeLoss
256000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
12659000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
12659000 usd
CY2024Q1 us-gaap Area Of Land
AreaOfLand
93967 sqft
CY2024Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
8568000 usd
CY2023Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
8211000 usd
CY2024Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
5454000 usd
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
4460000 usd
CY2024Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
668000 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
489000 usd
CY2024Q1 us-gaap Inventory Gross
InventoryGross
14690000 usd
CY2023Q4 us-gaap Inventory Gross
InventoryGross
13160000 usd
CY2024Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1007000 usd
CY2023Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1007000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
13683000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
12153000 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_842_eus-gaap--ConcentrationRiskCreditRisk_zNYAtG7bQcZk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_z9Ldm3sKakPd">Concentration of Credit Risk</span>:</i></b> The Company’s accounts receivables as of March 31, 2024 consist of U.S. government agencies (<span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20231002__20240331__srt--TitleOfIndividualAxis__custom--USGovernmentAgenciesMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zO4ljv8cWXu8" title="Concentration risk percentage">11</span>%), four major U.S. defense contractors (<span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20231002__20240331__srt--TitleOfIndividualAxis__custom--MajorUSDefenseContractorOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z82NGiPT5nA9" title="Concentration risk percentage">25</span>%, <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20231002__20240331__srt--TitleOfIndividualAxis__custom--MajorUSDefenseContractorTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zk8RCtpQAqR4" title="Concentration risk percentage">14</span>%, <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20231002__20240331__srt--TitleOfIndividualAxis__custom--MajorUSDefenseContractorThreeMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zytm0QDG3WXi" title="Concentration risk percentage">8</span>% and <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20231002__20240331__srt--TitleOfIndividualAxis__custom--MajorUSDefenseContractorFourMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zZpR5HikmQV9" title="Concentration risk percentage">5</span>%, respectively), one commercial customer (<span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20231002__20240331__srt--TitleOfIndividualAxis__custom--OneCommercialCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_znt5Wc4Qjdb6" title="Concentration risk percentage">11</span>%) and all other customers (<span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20231002__20240331__srt--TitleOfIndividualAxis__custom--AllOtherCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z2j9iharQqki" title="Concentration risk percentage">26</span>%). The Company does not believe that this concentration results in undue credit risk because of the financial strength of the customers and the Company’s long history with these customers.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1 OPXS Warranty Reserve
WarrantyReserve
69000 usd
CY2023Q4 OPXS Warranty Reserve
WarrantyReserve
75000 usd
CY2023Q1 OPXS Warranty Reserve
WarrantyReserve
229000 usd
CY2023Q4 OPXS Warranty Reserve
WarrantyReserve
75000 usd
CY2022Q4 OPXS Warranty Reserve
WarrantyReserve
169000 usd
CY2024Q1 OPXS Product Warranty Accrual Warranty Costs
ProductWarrantyAccrualWarrantyCosts
-5000 usd
CY2023Q2 OPXS Product Warranty Accrual Warranty Costs
ProductWarrantyAccrualWarrantyCosts
-16000 usd
OPXS Product Warranty Accrual Warranty Costs
ProductWarrantyAccrualWarrantyCosts
-37000 usd
OPXS Product Warranty Accrual Warranty Costs
ProductWarrantyAccrualWarrantyCosts
-16000 usd
CY2024Q1 OPXS Product Warranty Accrual Reserved For New Product Shipping
ProductWarrantyAccrualReservedForNewProductShipping
26000 usd
CY2023Q2 OPXS Product Warranty Accrual Reserved For New Product Shipping
ProductWarrantyAccrualReservedForNewProductShipping
60000 usd
OPXS Product Warranty Accrual Reserved For New Product Shipping
ProductWarrantyAccrualReservedForNewProductShipping
64000 usd
OPXS Product Warranty Accrual Reserved For New Product Shipping
ProductWarrantyAccrualReservedForNewProductShipping
119000 usd
CY2023Q2 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
-7000 usd
us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
-33000 usd
us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
-6000 usd
CY2024Q1 us-gaap Product Warranty Accrual Period Increase Decrease
ProductWarrantyAccrualPeriodIncreaseDecrease
26000 usd
CY2023Q2 us-gaap Product Warranty Accrual Period Increase Decrease
ProductWarrantyAccrualPeriodIncreaseDecrease
53000 usd
us-gaap Product Warranty Accrual Period Increase Decrease
ProductWarrantyAccrualPeriodIncreaseDecrease
31000 usd
us-gaap Product Warranty Accrual Period Increase Decrease
ProductWarrantyAccrualPeriodIncreaseDecrease
113000 usd
CY2024Q1 OPXS Warranty Reserve
WarrantyReserve
69000 usd
OPXS Decreased Related To Temporary Tax Adjustments
DecreasedRelatedToTemporaryTaxAdjustments
47000 usd
CY2023Q2 OPXS Warranty Reserve
WarrantyReserve
266000 usd
CY2024Q1 OPXS Warranty Reserve
WarrantyReserve
69000 usd
CY2023Q2 OPXS Warranty Reserve
WarrantyReserve
266000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84B_eus-gaap--UseOfEstimates_z0vK9yDoQD8i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86A_zSETYRGkzNMh">Use of Estimates</span>: </i></b>The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statement and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from the estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1 OPXS Revenue From Customer Deposit Liabilities
RevenueFromCustomerDepositLiabilities
0 usd
OPXS Revenue From Customer Deposit Liabilities
RevenueFromCustomerDepositLiabilities
0 usd
CY2023Q2 OPXS Revenue From Customer Deposit Liabilities
RevenueFromCustomerDepositLiabilities
1000 usd
OPXS Revenue From Customer Deposit Liabilities
RevenueFromCustomerDepositLiabilities
223000 usd
CY2024Q1 us-gaap Deposit Contracts Liabilities
DepositContractsLiabilities
481000 usd
CY2023Q4 us-gaap Deposit Contracts Liabilities
DepositContractsLiabilities
481000 usd
CY2024Q1 OPXS Accrued Selling Expense Current
AccruedSellingExpenseCurrent
258000 usd
CY2023Q4 OPXS Accrued Selling Expense Current
AccruedSellingExpenseCurrent
336000 usd
CY2024Q1 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
250000 usd
CY2023Q4 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
336000 usd
CY2022Q4 OPXS Contract Value
ContractValue
3100000 usd
CY2024Q1 OPXS Contract Loss Reserves Current
ContractLossReservesCurrent
150000 usd
CY2023Q4 OPXS Contract Loss Reserves Current
ContractLossReservesCurrent
243000 usd
CY2024Q1 OPXS Change In Estimate On Contract Losses
ChangeInEstimateOnContractLosses
120000 usd
OPXS Change In Estimate On Contract Losses
ChangeInEstimateOnContractLosses
30000 usd
CY2024Q1 OPXS Amount Shipped Against Existing Loss Reserves
AmountShippedAgainstExistingLossReserves
38000 usd
OPXS Amount Shipped Against Existing Loss Reserves
AmountShippedAgainstExistingLossReserves
63000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8523000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
9000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
117000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1347000 usd
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
157000 usd
CY2024Q1 OPXS Warranty Expense
WarrantyExpense
26000 usd
CY2024Q1 us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
23798000 usd
CY2024Q1 us-gaap Segment Expenditure Addition To Long Lived Assets
SegmentExpenditureAdditionToLongLivedAssets
1139000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6370000 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
8000 usd
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
85000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
607000 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
17000 usd
CY2023Q2 OPXS Warranty Expense
WarrantyExpense
53000 usd
CY2023Q2 us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
19850000 usd
CY2023Q2 us-gaap Segment Expenditure Addition To Long Lived Assets
SegmentExpenditureAdditionToLongLivedAssets
56000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15492000 usd
us-gaap Interest Expense
InterestExpense
16000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
209000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1893000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
270000 usd
OPXS Warranty Expense
WarrantyExpense
31000 usd
us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
23798000 usd
us-gaap Segment Expenditure Addition To Long Lived Assets
SegmentExpenditureAdditionToLongLivedAssets
1197000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10410000 usd
us-gaap Interest Expense
InterestExpense
8000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
166000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
325000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
53000 usd
OPXS Warranty Expense
WarrantyExpense
113000 usd
us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
19850000 usd
us-gaap Segment Expenditure Addition To Long Lived Assets
SegmentExpenditureAdditionToLongLivedAssets
146000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
322000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
656000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
662000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
679000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
572000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
83000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2974000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
317000 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
2657000 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2490000 usd
CY2024Q1 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.050 pure
OPXS Lessee Operating Lease Effective Date
LesseeOperatingLeaseEffectiveDate
2021-01-11
CY2024Q1 us-gaap Deferred Rent Credit
DeferredRentCredit
167000 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
630000 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2027000 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
40000 shares
CY2023Q2 OPXS Sharebased Compensation Arrangement By Sharebased Payment Award Options Amortized Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAmortizedGrantDateFairValue
124000 usd
CY2023Q2 OPXS Sharebased Compensation Arrangement By Sharebased Payment Award Options Amortized Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAmortizedGrantDateFairValue
320000 usd
OPXS Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Performance Period Start
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPerformancePeriodStart
2023-10-02
OPXS Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Performance Period End
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsPerformancePeriodEnd
2028-10-01
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y5M1D
OPXS Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Time Steps In Simulation
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsTimeStepsInSimulation
1,365
OPXS Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Time Steps Per Year
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsTimeStepsPerYear
252
CY2024Q1 us-gaap Share Price
SharePrice
3.04
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.500 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0337 pure
OPXS Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Cost Of Equity
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCostOfEquity
0.115 pure
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
157000 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
17000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
270000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
53000 usd
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
203000 usd
CY2023Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
462000 usd
CY2024Q1 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
1000000 usd
CY2024Q1 us-gaap Long Term Purchase Commitment Milestones
LongTermPurchaseCommitmentMilestones
The acquisition included transaction costs of $30 thousand for legal fees and a contingent liability for payment against an earnout agreement based on meeting certain revenue milestones.
CY2024Q1 us-gaap Asset Acquisition Contingent Consideration Liability Current
AssetAcquisitionContingentConsiderationLiabilityCurrent
83000 usd
CY2024Q1 us-gaap Asset Acquisition Contingent Consideration Liability Current
AssetAcquisitionContingentConsiderationLiabilityCurrent
86000 usd
CY2024Q1 us-gaap Asset Acquisition Contingent Consideration Liability
AssetAcquisitionContingentConsiderationLiability
238000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1113000 usd
CY2024Q1 OPXS Change In Fair Value Of Contingent Liability
ChangeInFairValueOfContingentLiability
3000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
27000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1089000 usd
CY2024Q1 OPXS Earnout Unit Discount Rate
EarnoutUnitDiscountRate
0.1201 pure
CY2024Q1 OPXS Earnout Unit Discount Rate
EarnoutUnitDiscountRate
0.1238 pure
CY2024Q1 us-gaap Debt Instrument Redemption Period End Date
DebtInstrumentRedemptionPeriodEndDate
2025-07-18
CY2024Q1 us-gaap Debt Instrument Redemption Period End Date
DebtInstrumentRedemptionPeriodEndDate
2025-07-18
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P1Y6M
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P1Y3M18D
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.300 pure
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.300 pure
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0500 pure
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0527 pure
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Discount For Postvesting Restrictions
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions
0.0635 pure
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Discount For Postvesting Restrictions
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions
0.0610 pure
CY2024Q1 us-gaap Liquidation Date1
LiquidationDate1
2025-08-02
CY2024Q1 us-gaap Liquidation Date1
LiquidationDate1
2025-08-02
CY2024Q1 OPXS Indicated Fair Value Of Earnout Rounded
IndicatedFairValueOfEarnoutRounded
83000000 usd
CY2024Q1 OPXS Indicated Fair Value Of Earnout Rounded
IndicatedFairValueOfEarnoutRounded
86000000 usd
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6844362 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6763070 shares

Files In Submission

Name View Source Status
0001493152-24-019107-index-headers.html Edgar Link pending
0001493152-24-019107-index.html Edgar Link pending
0001493152-24-019107.txt Edgar Link pending
0001493152-24-019107-xbrl.zip Edgar Link pending
ex10-1.htm Edgar Link pending
ex10-2.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
opxs-20240331.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
opxs-20240331_cal.xml Edgar Link unprocessable
opxs-20240331_def.xml Edgar Link unprocessable
opxs-20240331_lab.xml Edgar Link unprocessable
opxs-20240331_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable